![Adaptive parallel Simon two-stage design. " R " refers to randomization... | Download Scientific Diagram Adaptive parallel Simon two-stage design. " R " refers to randomization... | Download Scientific Diagram](https://www.researchgate.net/publication/295895592/figure/fig6/AS:335634381197314@1457032880731/Adaptive-parallel-Simon-two-stage-design-R-refers-to-randomization-of-patients.png)
Adaptive parallel Simon two-stage design. " R " refers to randomization... | Download Scientific Diagram
![Optimal, minimax and admissible two-stage design for phase II oncology clinical trials | BMC Medical Research Methodology | Full Text Optimal, minimax and admissible two-stage design for phase II oncology clinical trials | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-020-01017-8/MediaObjects/12874_2020_1017_Fig3_HTML.png)
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials | BMC Medical Research Methodology | Full Text
Optimal two-stage design of single arm Phase II clinical trials based on median event time test | PLOS ONE
![A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials. | Semantic Scholar A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a6e62b16707086a034f7512cf8cfb86ac684a0ab/4-Table1-1.png)
A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials. | Semantic Scholar
![Two-stage optimal designs with survival endpoint when the follow-up time is restricted | BMC Medical Research Methodology | Full Text Two-stage optimal designs with survival endpoint when the follow-up time is restricted | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-019-0696-x/MediaObjects/12874_2019_696_Fig2_HTML.png)
Two-stage optimal designs with survival endpoint when the follow-up time is restricted | BMC Medical Research Methodology | Full Text
![Overview of Standard Phase II Design Issues Elizabeth Hill, PhD Associate Professor of Biostatistics Hollings Cancer Center Medical University of South. - ppt download Overview of Standard Phase II Design Issues Elizabeth Hill, PhD Associate Professor of Biostatistics Hollings Cancer Center Medical University of South. - ppt download](https://images.slideplayer.com/39/10973902/slides/slide_10.jpg)
Overview of Standard Phase II Design Issues Elizabeth Hill, PhD Associate Professor of Biostatistics Hollings Cancer Center Medical University of South. - ppt download
Optimal two-stage design of single arm Phase II clinical trials based on median event time test | PLOS ONE
Optimal two-stage design of single arm Phase II clinical trials based on median event time test | PLOS ONE
![A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials. | Semantic Scholar A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a6e62b16707086a034f7512cf8cfb86ac684a0ab/5-Table3-1.png)
A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials. | Semantic Scholar
![Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately | JCO Precision Oncology Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2021/po.2021.5/po.21.00276/20220127/images/large/po.21.00276t2.jpeg)
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately | JCO Precision Oncology
![Minimax and admissible adaptive two-stage designs in phase II clinical trials | BMC Medical Research Methodology | Full Text Minimax and admissible adaptive two-stage designs in phase II clinical trials | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-016-0194-3/MediaObjects/12874_2016_194_Fig3_HTML.gif)
Minimax and admissible adaptive two-stage designs in phase II clinical trials | BMC Medical Research Methodology | Full Text
![Optimal, minimax and admissible two-stage design for phase II oncology clinical trials | BMC Medical Research Methodology | Full Text Optimal, minimax and admissible two-stage design for phase II oncology clinical trials | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-020-01017-8/MediaObjects/12874_2020_1017_Fig4_HTML.png)